AGRX Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (9 geg. 2024 @ 22:46):

Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States...

Stats
Šios dienos apimtis	43 261.00
Vidutinė apimtis	737 255
Rinkos kapitalizacija	2.65M
EPS	$-1.510 ( 2024-03-28 )
Kita pelno data	( $-0.510 ) 2024-06-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0600
ATR14	$0.0140 (3.73%)

Insider Trading

Date	Person	Action	Amount	type
2023-10-03	Coiante Scott M	Buy	20 000	Common Stock
2023-08-16	Coiante Scott M	Sell	0	Common Stock
2023-06-28	Welsh Amy	Buy	13 500	Common Stock
2023-06-28	Welsh Amy	Buy	4 500	Employee Stock Option (Right to Buy)
2023-06-28	Korner Paul	Buy	13 500	Common Stock

INSIDER POWER
99.60
Last 98 transactions
Buy: 13 666 273 \| Sell: 187 248

Agile Therapeutics Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
CFRX	0.977
WISA	0.969
PXS	0.967
FWRD	0.967
IONM	0.964
PETS	0.962
IRDM	0.962
BHTG	0.961
CYXT	0.96
IVAC	0.959

10 Labiausiai neigiamai susiję koreliacijos
CRZN	-0.984
HERA	-0.981
AGGR	-0.98
HERAU	-0.979
LDHA	-0.978
TBSA	-0.976
LVRA	-0.976
ACQR	-0.974
LEGA	-0.974
AHRN	-0.973

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Agile Therapeutics Inc Finansinės ataskaitos

Annual	2023
Pajamos:	$19.59M
Bruto pelnas:	$10.62M (54.18 %)
EPS:	$-0.00670

FY	2023
Pajamos:	$19.59M
Bruto pelnas:	$10.62M (54.18 %)
EPS:	$-0.00670

FY	2022
Pajamos:	$10.88M
Bruto pelnas:	$4.05M (37.19 %)
EPS:	$-58.79

FY	2021
Pajamos:	$4.10M
Bruto pelnas:	$-6.62M (-161.35 %)
EPS:	$-0.884

Financial Reports:

No articles found.

Agile Therapeutics Inc

Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.

Realaus laiko atnaujinimai Agile Therapeutics Inc [AGRX]

Upcoming Earnings Alert